Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, is attracting investor attention with a compelling potential upside of 63.66%. As a medical device company headquartered in Durham, North Carolina, Bioventus focuses on innovative solutions for pain relief and musculoskeletal therapies, both domestically and internationally.

The company’s current market cap stands at $593.41 million, and its shares are trading at $8.86. Notably, Bioventus occupies a strategic position within the medical devices industry, offering products ranging from intra-articular injections for osteoarthritis to advanced ultrasonic surgical systems.

An examination of Bioventus’s price data reveals a 52-week range between $6.14 and…